AB122

· Arcus Biosciences

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for AB122, covering 2024-05-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: AB154 Combined With AB122 for Recurrent Glioblastoma [EARLY_Phase 1]